ELIXYS - a fully automated, three-reactor high-pressure radiosynthesizer for development and routine production of diverse PET tracers
Authors:
- Mark LazariMLMark Lazari
- Kevin M QuinnKQKevin M Quinn
- Shane B ClaggettSCShane B Claggett
- Jeffrey CollinsJCJeffrey Collins
- Gaurav J ShahGSGaurav J Shah
- Henry E HermanHHHenry E Herman
- Brandon MaragliaBMBrandon Maraglia
- Michael E PhelpsMPMichael E Phelps
- Melissa D MooreMMMelissa D Moore
- R Michael van DamRDR Michael van Dam
Open Access
- 12 July 2013
- journal article
- Published by Springer Nature in EJNMMI Research
- Vol. 3 (1) , 52
Abstract
Background: Automated radiosynthesizers are vital for routine production of positron-emission tomography tracers to minimize radiation exposure to operators and to ensure reproducible synthesis yields. The recent trend in the synthesizer industry towards the use of disposable kits aims to simplify setup and operation for the user, but often introduces several limitations related to temperature and chemical compatibility, thus requiring reoptimization of protocols developed on non-cassette-based systems. Radiochemists would benefit from a single hybrid system that provides tremendous flexibility for development and optimization of reaction conditions while also providing a pathway to simple, cassette-based production of diverse tracers. Methods: We have designed, built, and tested an automated three-reactor radiosynthesizer (ELIXYS) to provide a flexible radiosynthesis platform suitable for both tracer development and routine production. The synthesizer is capable of performing high-pressure and high-temperature reactions by eliminating permanent tubing and valve connections to the reaction vessel. Each of the three movable reactors can seal against different locations on disposable cassettes to carry out different functions such as sealed reactions, evaporations, and reagent addition. A reagent and gas handling robot moves sealed reagent vials from storage locations in the cassette to addition positions and also dynamically provides vacuum and inert gas to ports on the cassette. The software integrates these automated features into chemistry unit operations (e.g., React, Evaporate, Add) to intuitively create synthesis protocols. 2-Deoxy-2-[18F]fluoro-5-methyl-β-l-arabinofuranosyluracil (l-[18F]FMAU) and 2-deoxy-2-[18F]fluoro-β-d-arabinofuranosylcytosine (d-[18F]FAC) were synthesized to validate the system. Results: l-[18F]FMAU and d-[18F]FAC were successfully synthesized in 165 and 170 min, respectively, with decay-corrected radiochemical yields of 46% ± 1% (n = 6) and 31% ± 5% (n = 6), respectively. The yield, repeatability, and synthesis time are comparable to, or better than, other reports. d-[18F]FAC produced by ELIXYS and another manually operated apparatus exhibited similar biodistribution in wild-type mice. Conclusion: The ELIXYS automated radiosynthesizer is capable of performing radiosyntheses requiring demanding conditions: up to three reaction vessels, high temperatures, high pressures, and sensitive reagents. Such flexibility facilitates tracer development and the ability to synthesize multiple tracers on the same system without customization or replumbing. The disposable cassette approach simplifies the transition from development to production.Keywords
This publication has 23 references indexed in Scilit:
- Simplified programming and control of automated radiosynthesizers through unit operationsEJNMMI Research, 2013
- The improved syntheses of 5-substituted 2′-[18F]fluoro-2′-deoxy-arabinofuranosyluracil derivatives ([18F]FAU, [18F]FEAU, [18F]FFAU, [18F]FCAU, [18F]FBAU and [18F]FIAU) using a multistep one-pot strategyNuclear Medicine and Biology, 2011
- Automated synthesis of 2′-deoxy-2′-[18F]fluoro-5-methyl-1-β-d-arabinofuranosyluracil ([18F]-FMAU) using a one reactor radiosynthesis moduleNuclear Medicine and Biology, 2010
- Fluorine-18 radiopharmaceuticals beyond [18F]FDG for use in oncology and neurosciencesNuclear Medicine and Biology, 2010
- Teflon radiolysis as the major source of carrier in fluorine‐18Journal of Labelled Compounds and Radiopharmaceuticals, 2009
- Noninvasive prediction of tumor responses to gemcitabine using positron emission tomographyProceedings of the National Academy of Sciences, 2009
- Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2′-deoxycytidine analogNature Medicine, 2008
- Synthesis of 2′-deoxy-2′-[18F]fluoro-β-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferationNuclear Medicine and Biology, 2003
- Synthesis of [18F]‐labeled 2′‐deoxy‐2′‐fluoro‐5‐methyl‐1‐β‐D‐arabinofuranosyluracil ([18F]‐FMAU)Journal of Labelled Compounds and Radiopharmaceuticals, 2002
- Automated injection of a radioactive sample for preparative HPLC with feedback controlInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1990